✓
Open
20 Feb 2026
✓
Close
24 Feb 2026
3
Allotment
—
✓
Listing
Fri, Feb 27, 2026
Price Band
₹75 to ₹79
Issue Size
2,08,86,200 shares (agg. up to ₹165 Cr)
Lot Size
189 Shares
Listing Date
Fri, Feb 27, 2026
Latest GMP
₹0
Est. Gain
0%
✦ AI Insight
GMP Trend
27-02-2026₹0Est. ₹79+0%
26-02-2026₹0Est. ₹79+0%
25-02-2026₹-4Est. ₹75-5.06%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 5.23x |
Restated Financials (₹ Cr.)
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Total Income | 49.75 | 70.96 | 48.15 | 44.26 |
| Profit After Tax | 12.51 | 19.13 | 10.32 | 13.53 |
| EBITDA | 18.95 | 28.63 | 19.27 | 20.07 |
| NET Worth | 58.85 | 46.30 | 26.99 | 22.73 |
| Reserves and Surplus | 28.16 | 15.60 | 26.00 | 21.74 |
| Total Borrowing | 22.51 | 18.93 | 15.73 | 9.78 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Nephrocare Health Services Ltd. | Mainboard | ₹871.05 Cr | ₹460 | 63.52 | ₹471.25 | +2.45% | ₹744.10 |
| Modern Diagnostic & Research Centre Ltd. | SME | ₹36.89 Cr | ₹90 | 11.04 | ₹94.99 | +5.54% | ₹50.70 |
| Invicta Diagnostic Ltd. | SME | ₹28.12 Cr | ₹85 | 14.51 | ₹96.70 | +13.76% | ₹67.50 |
| Star Imaging & Path Lab Ltd. | SME | ₹69.47 Cr | ₹142 | 12.01 | ₹135.95 | -4.26% | ₹86.45 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure towards establishment of New IVF Centers of the Company. | 50.00 |
| 2 | Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company. | 20.00 |
| 3 | General Corporate Purposes | 12.28 |
| 4 | Issue Expenses | 14.15 |
| Total | 96.43 |
About Gaudium IVF IPO
Updated on Aug 5, 2026
Contact Details
Gaudium IVF & Women Health Ltd. AddressB1/51, Janak PuriB-1New Delhi, New Delhi, 110058011-4885 8585compliance@gaudiumivfcentre.comVisit Website